Copyright
©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 106795
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.106795
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.106795
Table 1 The regulatory axis of taurine upregulated gene 1 in hepatocellular carcinoma
Function | Pathway | Target miRNA | Target protein | Molecular mechanism | TUG1 role | Ref. |
Proliferation, apoptosis, metastasis, angiogenesis | ||||||
LncRNA-protein interaction | - | - | EZH2/SUZ12/KLF2 | SP1-upregulated TUG1 interacts with PRC2 subunit, EZH2 and SUZ12, to suppress KLF2 | Tumor-promoting | Huang et al[68] |
- | - | - | AFP | Repression of TUG1 mediated by Triiodothyronine reduce AFP expression | Tumor-promoting | Lin et al[69] |
LncRNA-protein interaction | - | - | USF1/ROMO1 | TUG1 recruits USF1 to ROMO1 promoter, activating its transcription | Tumor-promoting | Liu et al[70] |
MiRNA sponge/ceRNA | - | MiR-34a-5p | VEGFA | TUG1 sequesters miR-34a-5p, a negative regulator of VEGFA | Tumor-promoting | Dong et al[71] |
MiRNA sponge/ceRNA | Hedgehog signaling pathway | MiR-132 | Shh | TUG1 sequesters miR-132, a negative regulator of Shh | Tumor-promoting | Li et al[72] |
- | - | - | AURKA | Overexpression of TUG1 is positively correlated with expression of AURKA | Tumor-promoting | Kang et al[73] |
MiRNA sponge/ceRNA | Phosphatidylinositol 3-kinase/AKT pathway | MiR-137 | AKT2 | TUG1 sequesters miR-137, a negative regulator of AKT2 | Tumor-promoting | Li et al[74] |
MiRNA sponge/ceRNA | - | MiR-142-3p | ZEB1 | TUG1 sequesters miR-142-3p, a negative regulator of ZEB1 | Tumor-promoting | He et al[75] |
MiRNA sponge/ceRNA | JAK2/STAT3 pathway | MiR-144 | JAK2 | TUG1 sequesters miR-144, a negative regulator of JAK2 | Tumor-promoting | Lv et al[76] |
MiRNA sponge/ceRNA | JAK2/STAT3 pathway | MiR-204-5p | JAK2 | TUG1 sequesters miR-204-5p, a negative regulator of JAK2 | Tumor-promoting | Yuan et al[77] |
MiRNA sponge/ceRNA | Mammalian target of rapamycin/S6K pathway | MiR-144-3p | RRAGD | TUG1 sequesters miR-144-3p, a negative regulator of RRAGD | Tumor-promoting | Chen et al[78] |
MiRNA sponge/ceRNA | - | MiR-216b-5p | DLX2 | TUG1 sequesters miR-216b-5p, a negative regulator of DLX2 | Tumor-promoting | Dai et al[66] |
MiRNA sponge/ceRNA | - | MiR-29a | IFITM3 | TUG1 sequesters miR-29a, a negative regulator of IFITM3 | Tumor-promoting | Liu et al[79] |
MiRNA sponge/ceRNA | - | MiR-29c-3p | COL1A1 | TUG1 sequesters miR-29c-3p, a negative regulator of COL1A1 | Tumor-promoting | Zhao et al[80] |
MiRNA sponge/ceRNA | - | MiR-328-3p | SRSF9 | TUG1 sequesters miR-328-3p, a negative regulator of SRSF9 | Tumor-promoting | Liu et al[65] |
MiRNA sponge/ceRNA | - | MiR-1-3p | IGF1 | TUG1 sequesters miR-1-3p, a negative regulator of IGF1 | Tumor-promoting | Tang et al[81] |
MiRNA sponge/ceRNA | - | MiR-4726-5p | MUC1 | TUG1 sequesters miR-4726-5p, a negative regulator of MUC1 | Tumor-promoting | Tang et al[82] |
Immune response | ||||||
MiRNA sponge/ceRNA | - | MiR-335-5p | CXCR4 | TUG1 sequesters miR-335-5p, a negative regulator of CXCR4 | Tumor-promoting | Xie et al[83] |
MiRNA sponge/ceRNA | - | MiR-582-5p | Siglec-15 | TUG1 sequesters miR-582-5p, a negative regulator of Siglec-15 | Tumor-promoting | Ren et al[84] |
- | JAK2/STAT3 pathway | - | PD-L1 | Overexpression of TUG1 is positively correlated with expression of PD-L1 | Tumor-promoting | Wu et al[85] |
MiRNA sponge/ceRNA | - | MiR-141, miR-340 | PD-L1, CD47 | TUG1 sequesters miR-141 and miR-340, which serve as a negative regulator of PD-L1 and CD47, respectively | Tumor-promoting | Xi et al[86] |
LncRNA-protein interaction | - | - | YBX1/PD-L1/CD47 | TUG1 directly interacts with YBX1 and recruits to the PD-L1 and CD47 promoters, activating their transcription | Tumor-promoting | Xi et al[86] |
Glycolysis | ||||||
LncRNA-protein interaction | - | MiR-455-3p | EZH2/p21/AMPKβ2 | By interacting with EZH2 of PRC2, TUG1 silences the p21 promoter, thereby reducing p21 regulation on E2F transcription factor 1, which controls the level of tumor-promoting miR-455-3p targeting AMPKβ2 | Tumor-promoting | Lin et al[87] |
MiRNA sponge/ceRNA | - | MiR-524-5p | SIX1 | TUG1 sequesters miR-524-5p, a negative regulator of SIX1 | Tumor-promoting | Lu et al[67] |
Table 2 The regulatory axis of taurine upregulated gene 1 in non-cancerous liver disease
Function | Target miRNA | Target protein | Molecular mechanism | TUG1 role | Ref. |
Liver injury | |||||
- | - | - | Overexpression of TUG1 suppresses endoplasmic reticulum stress, reduces apoptosis, and upregulates anti-apoptotic proteins | Cryoprotective | Su et al[134] |
MiRNA sponge/ceRNA | MiR-194 | SIRT1 | TUG1 sequesters miR-194, a negative regulator of SIRT1 | Anti-apoptotic, anti-inflammatory | Gu et al[135] |
MiRNA sponge/ceRNA | MiR-140-5p | TNF | TUG1 sequesters miR-140-5p, a negative regulator of TNF-α | Pro-apoptotic, pro-inflammatory | Liu et al[136] |
Liver fibrosis/cirrhosis | |||||
- | MiR-29b | COL1A1/α-SMA | Overexpression of TUG1 is positively correlated with expression of COL1A1 and α-SMA while negatively correlated with miR-29b | Pro-fibrotic | Han et al[137] |
- | - | PDK4 | Overexpression of TUG1 is positively correlated with expression of PDK4 | Anti-ferroptotic | Zhang et al[138] |
MiRNA sponge/ceRNA | MiR-142-3p | ATG5 | TUG1 sequesters miR-142-3p, a negative regulator of ATG5 | Pro-autophagic endothelial-mesenchymal transition-promoting | Zhang et al[139] |
Metabolic dysfunction–associated steatotic liver disease | |||||
MiRNA sponge/ceRNA | MiR-1934-3p | SelenoF | TUG1 sequesters miR-1934-3p, a negative regulator of SelenoF | Glucose-lipid metabolism regulator | Wang et al[140] |
- Citation: Boonto T, Ariyachet C. Deciphering the role of taurine-upregulated gene 1 in liver diseases: Mechanisms, clinical relevance, and emerging therapeutic opportunities. World J Hepatol 2025; 17(7): 106795
- URL: https://www.wjgnet.com/1948-5182/full/v17/i7/106795.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i7.106795